Literature DB >> 31349048

Prognostic implications of co-occurring dermatologic and gastrointestinal toxicity from immune checkpoint inhibition therapy for advanced malignancies: A retrospective cohort study.

Gabriel E Molina1, Ian M Allen2, Michael S Hughes3, Leyre Zubiri4, Hang Lee5, Meghan J Mooradian4, Kerry L Reynolds4, Michael Dougan6, Steven T Chen7.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31349048     DOI： 10.1016/j.jaad.2019.07.049

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  5 in total

1.  Contribution of the Skin-Gut Axis to Immune-Related Adverse Events with Multi-System Involvement.

Authors:  Alyce M Kuo; Lukas Kraehenbuehl; Stephanie King; Donald Y M Leung; Elena Goleva; Andrea P Moy; Mario E Lacouture; Neil J Shah; David M Faleck
Journal:  Cancers (Basel)       Date:  2022-06-17       Impact factor: 6.575

Review 2.  High Grade Dermatologic Adverse Events Associated With Immune Checkpoint Blockade for Cancer.

Authors:  Alyce M Kuo; Alina Markova
Journal:  Front Med (Lausanne)       Date:  2022-06-13

Review 3.  Time to dissect the autoimmune etiology of cancer antibody immunotherapy.

Authors:  Michael Dougan; Massimo Pietropaolo
Journal:  J Clin Invest       Date:  2020-01-02       Impact factor: 14.808

4.  New Discoveries and Updates on Cutaneous Adverse Drug Reactions Presented at the 24th World Congress of Dermatology, Milan, Italy, 2019.

Authors:  Felix L Chan; Neil H Shear; Nidhi Shah; Cristina Olteanu; Rena Hashimoto; Roni P Dodiuk-Gad
Journal:  Drug Saf       Date:  2020-02       Impact factor: 5.228

Review 5.  Immune Checkpoint Inhibitor-Associated Colitis: From Mechanism to Management.

Authors:  Liansha Tang; Jialing Wang; Nan Lin; Yuwen Zhou; Wenbo He; Jiyan Liu; Xuelei Ma
Journal:  Front Immunol       Date:  2021-12-21       Impact factor: 7.561
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.